Could cytogenetics and minimal residual disease replace conventional risk criteria in adults with Ph-negative acute lymphoblastic leukaemia?

Authors: Giebel, Sebastian; Krawczyk-Kulis, Malgorzata¹; Kyrcz-Krzemien, Slawomira¹; Haus, Olga²; Jagoda, Krystyna¹; Piatkowska-Jakubas, Beata³; Paluszewska, Monika⁴; Seferynska, Ilona⁵; Chrobok, Aleksandra¹; Stella-Holowiecka, Beata¹; Kielbinski, Marek⁶; Holowiecki, Jerzy¹

Source: British Journal of Haematology, Volume 144, Number 6, March 2009 , pp. 970-972(3)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

Price: $48.00 plus tax (Refund Policy)

Keywords: acute lymphoblastic leukaemia; cytogenetics; minimal residual disease; prognostic factors; relapse

Document Type: Correspondence

DOI: http://dx.doi.org/10.1111/j.1365-2141.2008.07540.x

Affiliations: 1: Department of Haematology and Bone Marrow Transplantation, Silesian Medical University, Katowice 2: Department of Clinical Genetics, Bydgoszcz Medical Academy, Bydgoszcz 3: Department of Haematology, Collegium Medicum, Jagiellonian University, Cracow 4: Department of Haematology, Oncology and Internal Diseases, Medical University of Warsaw, Warsaw 5: Department of Haematology, Institute of Haematology and Transfusion Medicine, Warsaw 6: Department of Haematology, Haematopoietic Malignancies and Bone Marrow Transplantation, Wroclaw Medical Academy, Wroclaw, Poland., Email: sgiebel@poczta.onet.pl